NCT04311632View on ClinicalTrials.gov

A Dose Escalation Study in de Novo Renal Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

October 3, 2023

Study Completion Date

October 3, 2023

Conditions
Kidney Transplantation
Interventions
BIOLOGICAL

TCD601

Investigational Product

DRUG

Tacrolimus (TAC)

Standard of Care Concomitant Immunosuppression

DRUG

Corticosteroids (CS)

Standard of Care Concomitant Immunosuppression

DRUG

Mycophenolate Mofetil (MMF)

Standard of Care Concomitant Immunosuppression

DRUG

ATG

Standard of Care induction therapy in solid organ transplantation

Trial Locations (4)

30322

Emory University, Atlanta

66160

Kansas University Medical Center, Kansas City

02114

Massachusetts General Hospital, Boston

07039

Saint Barnabas Medical Center, Livingston

All Listed Sponsors
lead

ITB-Med LLC

INDUSTRY